Insider tradingForm 4
Beta Bionics, Inc. (BBNX) Insider Trading
14 open-market trades reported since Sep 3, 2026: 0 purchases worth $0 and 14 sales worth $3.03M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Mark Hopman | Chief Commercial Officer | 0 | $0 | 7 | $2.10M |
| Christy Jones | Director | 0 | $0 | 1 | $148K |
| Mike Mensinger | Chief Product Officer | 0 | $0 | 2 | $142K |
| Sean Saint | CEO | 0 | $0 | 2 | $436K |
| Stephen Feider | CFO | 0 | $0 | 1 | $128K |
| Steven Jon Russell | Chief Medical Officer | 0 | $0 | 1 | $81K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 16 | Mark HopmanChief Commercial Officer | ▼ SELL | $13K | |
| Oct 5 | Mark HopmanChief Commercial Officer | ▼ SELL | $7K | |
| Sep 23 | Christy JonesDirector | ▼ SELL10b5-1 | $148K | |
| Sep 18 | Mark HopmanChief Commercial Officer | ▼ SELL10b5-1 | $665K | |
| Sep 17 | Mark HopmanChief Commercial Officer | ▼ SELL10b5-1 | $620K | |
| Sep 17 | Mike MensingerChief Product Officer | ▼ SELL10b5-1 | $58K | |
| Sep 15 | Mark HopmanChief Commercial Officer | ▼ SELL10b5-1 | $12K | |
| Sep 10 | Mark HopmanChief Commercial Officer | ▼ SELL10b5-1 | $681K | |
| Sep 4 | Sean SaintCEO | ▼ SELL10b5-1 | $113K | |
| Sep 3 | Sean SaintCEO | ▼ SELL | $322K | |
| Sep 3 | Stephen FeiderCFO | ▼ SELL | $128K | |
| Sep 3 | Mark HopmanChief Commercial Officer | ▼ SELL | $102K | |
| Sep 3 | Mike MensingerChief Product Officer | ▼ SELL | $84K | |
| Sep 3 | Steven Jon RussellChief Medical Officer | ▼ SELL | $81K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings